Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30794604.
- Also identified by DOI 10.1371/journal.pone.0212236 and PMC identifier 6386446.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Viral-bacterial coinfections, such as with influenza A virus and Streptococcus pneumoniae (S.p.), are known to cause severe pneumonia. It is well known that the host response has an important role in disease. Interleukin-1β (IL-1β) is an important immune signaling cytokine responsible for inflammation and has been previously shown to contribute to disease severity in numerous infections. Other studies in mice indicate that IL-1β levels are dramatically elevated during IAV-S.p. coinfection. However, the regulation of IL-1β during coinfection is unknown. Here, we report the NLRP3 inflammasome is the major inflammasome regulating IL-1β activation during coinfection. Furthermore, elevated IL-1β mRNA expression is due to enhanced TLR2-MYD88 signaling, which increases the amount of pro-IL-1β substrate for the inflammasome to process. Finally, NLRP3 and high IL-1β levels were associated with increased bacterial load in the brain. Our results show the NLRP3 inflammasome is not protective during IAV-S.p. coinfection.
Medical subject headings
- Coinfection
- Influenza A Virus, H1N1 Subtype
- Interleukin-1beta
- Myeloid Differentiation Factor 88
- NLR Family, Pyrin Domain-Containing 3 Protein
- Orthomyxoviridae Infections
- Pneumococcal Infections
- Signal Transduction
- Streptococcus pneumoniae
- Toll-Like Receptor 2